Ezanic 20% Gel is a topical medication used in the treatment of acne. It effectively relieves symptoms such as lumps, redness and swelling associated with different forms of acne by killing the acne causing bacteria.
AZELAIC ACID GEL 20%
₦10,600.00
Description
Ezanic 20% Gel is a topical medication used in the treatment of acne. It effectively relieves symptoms such as lumps, redness and swelling associated with different forms of acne by killing the acne causing bacteria.
Related products
₦26,500.00Soothes immediately, repairs the skin and moisturizes for 24 hours. The skin is soothed and protected. Non-greasy melting texture, easy application and quick absorption. Fragrance-free. Tested on sensitive skin and mucous membranes under dermatological, pediatric and gynecological control.
₦23,500.00Anthelios Invisible Fluid Facial Sunscreen SPF 50+ is a lightweight daily facial sunscreen made for sensitive skin providing very high UVA/UVB protection while delivering an invisible finish.This fragrance-free, organic filter (also known as chemical) facial sunscreen is suitable normal to combination skin and also specifically designed for sensitive skin types. The invisible fluid sunscreen formula is non-greasy and non comedogenic, meaning it protects your skin without clogging pores. It is non eye-stinging.
₦23,500.00The formula is further supported with a cross polymer form of hyaluronic acid for comfort, pro vitamin B5 for hydration, and black carrot for added protection.
₦8,600.00Acretin 0.05% Cream is a topical (applied to the skin) cream which contains Tretinoin as active ingredient. Acretin helps the skin renew itself tretinoin is used to treat acne tretinoin is also used to reduce the appearance of fine wrinkles and mottled skin discoloration, and to make rough facial skin feel smoother Used to treat severe acne on face Reducethe appearance of fine wrinkles Make rough facial skin feel smoother Decreases the number and severity of acne pimples Promote quick healing of pimples that do develop
Reviews
There are no reviews yet.